Ottawa, Aug. 26, 2024 (GLOBE NEWSWIRE) -- The global multiple sclerosis (MS) diagnosis and treatment market size was valued at USD 22.14 billion in 2023 and is predicted to hit around USD 28.48 ...

A new report has revealed the prolonged time to diagnose multiple sclerosis (MS) and highlighted the urgent need for increased investment in MS research and enhanced awareness of the disease. The 'My ...

The results of research led by scientists at the University of Exeter, and at King’s College London, suggests that young people could be spared from going blind by a new genetic risk tool that could ...

Most people with multiple sclerosis (MS) are diagnosed between age 20 and 50, though it can occur in children as well as in older adults, according to the National Multiple Sclerosis Society (NMSS).

WEST PALM BEACH, Fla. — New research testing the newly proposed McDonald Criteria showed that 32% more patients with a radiological-only presentation and 28% more with an atypical presentation would ...

The first revision of the McDonald criteria in nearly a decade could improve diagnostic speed and accuracy in multiple sclerosis (MS), reducing the period of uncertainty and permitting earlier start ...

Multiple sclerosis (MS) is the most common chronic autoimmune disease of the central nervous system. An early and accurate diagnosis is crucial for improving the effectiveness of treatment and ...

Metabolomics—the systematic analysis of small-molecule metabolites—has emerged as a powerful approach to unravel the complex biochemical alterations underlying multiple sclerosis (MS). By profiling ...

The International Advisory Committee on Clinical Trials led a multinational panel updating the McDonald criteria, adding the optic nerve as a fifth anatomical location and allowing specific magnetic ...

Imaging is a crucial tool in the diagnosis of MS. Magnetic resonance imaging (MRI) reveals multiple demyelinated lesions scattered throughout the CNS, marked by inflammation, edema, glial reaction and ...

It's easy to assume that you'd know when you're dealing with a disease as serious as multiple sclerosis. But it can take years for people with MS to get a proper diagnosis. Now, new research suggests ...

Researchers have identified a biomarker that reveals who will develop multiple sclerosis (MS) years in advance. In work reported in Nature Medicine, scientists showed that one in ten people who ...